Healthcare & Medical Investment Corporation (TYO:3455)
Japan · Delayed Price · Currency is JPY 91,500
+100 (0.11%)
At close: Oct 9, 2026
TYO:3455 Ratios and Metrics
Market cap in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
| 41,391 | 43,500 | 38,107 | 47,346 | 58,239 | 46,828 | |
Market Cap Growth | -0.49% | 14.15% | -19.51% | -18.70% | 24.37% | 11.95% |
Enterprise Value | 85,142 | 83,977 | 77,703 | 84,882 | 95,578 | 78,514 |
Last Close Price | 91500.00 | 117555.57 | 97520.67 | 114542.26 | 134703.62 | 104622.10 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
PE Ratio | 15.87 | 20.97 | 18.33 | 22.36 | 24.49 | 25.53 |
PS Ratio | 7.82 | 8.39 | 7.57 | 9.71 | 11.64 | 11.28 |
PB Ratio | 1.07 | 1.12 | 0.99 | 1.23 | 1.50 | 1.43 |
P/OCF Ratio | 11.82 | 12.72 | 11.28 | 14.40 | 11.65 | 15.91 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
EV/Sales Ratio | 16.08 | 16.20 | 15.43 | 17.41 | 19.10 | 18.91 |
EV/EBITDA Ratio | 21.68 | 21.81 | 20.66 | 23.26 | 24.92 | 25.17 |
EV/EBIT Ratio | 31.73 | 31.95 | 30.21 | 33.65 | 35.15 | 36.48 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Debt / Equity Ratio | 1.21 | 1.20 | 1.11 | 1.02 | 1.00 | 1.01 |
Debt / EBITDA Ratio | 11.86 | 12.10 | 11.39 | 10.73 | 10.21 | 10.63 |
Net Debt / Equity Ratio | 1.14 | 1.14 | 1.06 | 0.97 | 0.97 | 0.96 |
Net Debt / EBITDA Ratio | 11.14 | 11.44 | 10.83 | 10.22 | 9.81 | 10.08 |
Asset Turnover | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | 0.06 |
Quick Ratio | 0.33 | 0.30 | 0.26 | 0.23 | 0.16 | 0.17 |
Current Ratio | 0.38 | 0.36 | 0.31 | 0.28 | 0.20 | 0.20 |
Return on Equity (ROE) | 5.38% | 5.37% | 5.39% | 5.46% | 6.62% | 5.57% |
Return on Assets (ROA) | 1.94% | 1.90% | 1.94% | 1.95% | 2.27% | 1.96% |
Return on Invested Capital (ROIC) | 3.15% | 3.15% | 3.23% | 3.23% | 3.77% | 3.26% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 8, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Earnings Yield | 5.01% | 4.77% | 5.46% | 4.47% | 4.08% | 3.92% |
Dividend Yield | 7.22% | 5.49% | 6.61% | 5.69% | 5.14% | - |
Payout Ratio | 111.79% | 110.00% | 112.28% | 116.05% | 93.23% | 110.03% |
Buyback Yield / Dilution | -0.02% | - | - | -0.05% | -15.54% | - |
Total Shareholder Return | 7.22% | 5.49% | 6.61% | 5.64% | -10.40% | - |